It took decades of dedication and research to reach a stage where heart health can be measured, risks understood, and interventions applied. Brain health presents a more difficult puzzle, and while we are still in the preliminary phases, we will succeed. That is our purpose: to conquer the next frontier in human health.
Cortex is on the horizon. While your brain undergoes changes every single day, the majority of people lack the necessary tools to track this evolution. We are here to provide a solution to this issue.
The @Neuron_Percepta trial operates on a fully decentralized model that surpasses the limitations of conventional trial structures. By managing recruitment remotely and shipping products directly to participants, the study can engage individuals regardless of their physical location.
This approach generates an unmatched depth of data through several key methods. Participants use wearable sensors for the continuous tracking of activity, sleep, and HRV. Additionally, the protocol includes at-home blood collection for monitoring the P-tau 217 biomarker, as well as cognitive assessments handled through specialized trial software.
To observe the project and track the results, please visit @molecule_DeSci.
‼️ The Cognition Store launches imminently. Our mission is to make brain health science available to all, ensuring it is backed by community capital and validated through research.
A new case of dementia arises every 3 seconds, and by the year 2050, projections indicate that 139 million people will be living with Alzheimer's or related conditions. While traditional pharmaceutical processes often require billions of dollars and take 10-15 years to complete drug development, our approach offers a stark contrast. The @Neuron_Percepta trial demonstrates the capacity of DeSci to operate independently of market forces while delivering significant, tangible results. Within a matter of months, we successfully raised $500K with the support of 115 individuals. We have since obtained IRB approval and initiated trials that monitor both biomarkers and cognitive performance. Our team remains dedicated to advancing solutions for diseases that impact millions of lives.
For the DeSci sector to thrive, it is essential to develop and contribute to services and products that hold lasting, intrinsic merit. We are fast approaching the debut of The Cognition Store, our digital marketplace dedicated to brain health products supported by Cerebrum DAO and the community. 🧠 Please keep an eye out for upcoming announcements regarding the launch and opportunities for exclusive discounts.
This week, Cerebrum has achieved a significant milestone. We remain dedicated to building and driving science ahead, staying focused despite any distractions. We are preparing to share a major update concerning Cognition, a platform designed for all individuals who wish to care for their brain health. 🧠
We are thrilled to share a significant breakthrough. The IRB has officially granted approval for our Percepta human trial. This initiative marks a monumental milestone as the first instance in the world of a decentralized, randomized controlled trial being crowd-funded through IP tokens. The study is designed to be double-blinded and will take place over a duration of 6 months. We want to extend our sincere gratitude to every individual who has backed this project. Please continue to check for updates via @Neuron_Percepta
The Cognition Store launches soon, with Percepta serving as our first case study in what is possible.
Percepta is a plant-based nutritional supplement supported by 50+ patents and 15 years of research, now entering a first-of-its-kind decentralized, double-blind, randomized controlled clinical study.
It represents a successful product and patent portfolio that we have tokenized as @Neuron_Percepta, with the community voting on and funding the clinical evidence study.
IPT holders retain an ownership stake in Neuron-Percepta as it progresses with the trial, the results, and the IP that emerges.
The Cognition Store is set to launch soon, featuring Percepta as our inaugural case study in what is possible.
Percepta is a plant-based nutritional supplement supported by 50+ patents and 15 years of research. It is now entering a first-of-its-kind decentralized, double-blind, randomized controlled clinical study.
We have tokenized this already successful product and patent portfolio as @Neuron_Percepta, enabling the community to vote on and fund the clinical evidence study.
IPT holders maintain an ownership stake in Neuron-Percepta as it progresses with the trial, the results, and the potential IP that emerges.
The Cognition Store is launching soon, featuring Percepta as our premier case study in what is possible. Percepta is a plant-based nutritional supplement supported by 50+ patents and 15 years of research, now entering a first-of-its-kind decentralized, double-blind, randomized controlled clinical study. This represents an already successful product and patent portfolio that we have tokenized as @Neuron_Percepta, empowering the community to vote on and fund the clinical evidence study. As a result, IPT holders maintain an ownership stake in Neuron-Percepta as it progresses through the trial, delivers results, and generates new IP in the months ahead.
We are excited to announce that our Cognition Store launches soon, featuring curated brain health products and discounts for NEURON holders:
➡️ Percepta (IPT @Neuron_Percepta) – A plant-based supplement backed by 30+ patents and 15 years of research. ➡️ Xponetiq – A brain health tool designed to track and improve activity, sleep, stress, mental stimulation, social connection, and nutrition.
Our Cognition Store is launching soon, featuring validated brain health products and member discounts for NEURON holders:
➡️ Percepta (IPT @Neuron_Percepta) – A plant-based supplement backed by 30+ patents and 15 years of research. ➡️ Xponetiq – A daily brain health tool to track and improve activity, sleep, stress, mental stimulation, social connection, and nutrition.
As we approach 2026, it is clear that 2025 marked a significant milestone for DeSci, showcasing its ability to outpace traditional institutions.
We extend our sincere appreciation to our partners who contributed to this achievement.
Acknowledgments go to @BioProtocol for their groundbreaking launch infrastructure and @NEURONGale for their successful debut. We also recognize @Molecule_dao for their innovative IP-NFT model, @vitadao for their support in early research funding, and @beakerdao for their assistance with @Transfidelity_. Additionally, we thank all the other bio DAOs that are instrumental in advancing this movement.
Four IPTs have been successfully launched, with clinical trials set to commence, all funded transparently by our communities.
This collaborative effort illustrates the power of an entire ecosystem moving forward in unison.
As we approach 2026, it's clear that 2025 showcased DeSci's remarkable ability to outpace conventional institutions.
We extend our heartfelt thanks to our partners who made this achievement possible.
Special acknowledgment goes to @BioProtocol for providing the launch infrastructure, and @NEURONGale for their successful initiation. We also appreciate @Molecule_dao for their innovative work on the IP-NFT model, and @vitadao for their financial support of early-stage research. Additionally, we are thankful to @beakerdao for their backing of @Transfidelity_, along with all the other bio DAOs that contribute to and promote this vital movement.
With four IPTs launched and clinical trials set to begin, all of this progress has been made possible through community-driven funding.
This is a prime example of what can be achieved when the entire ecosystem collaborates and advances together.
Here’s to a bright future as we move into 2026! #DeSci #Innovation #Collaboration